1. Home
  2. TZOO vs STRO Comparison

TZOO vs STRO Comparison

Compare TZOO & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Travelzoo

TZOO

Travelzoo

HOLD

Current Price

$5.84

Market Cap

75.0M

ML Signal

HOLD

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$15.93

Market Cap

85.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TZOO
STRO
Founded
1998
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
75.0M
85.0M
IPO Year
2002
2018

Fundamental Metrics

Financial Performance
Metric
TZOO
STRO
Price
$5.84
$15.93
Analyst Decision
Strong Buy
Hold
Analyst Count
3
8
Target Price
$17.67
$18.88
AVG Volume (30 Days)
159.0K
129.7K
Earning Date
02-25-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.66
N/A
Revenue
$89,923,000.00
$105,646,000.00
Revenue This Year
$11.57
$63.08
Revenue Next Year
$17.03
N/A
P/E Ratio
$8.75
N/A
Revenue Growth
6.58
N/A
52 Week Low
$5.58
$5.23
52 Week High
$24.85
$21.25

Technical Indicators

Market Signals
Indicator
TZOO
STRO
Relative Strength Index (RSI) 33.65 66.83
Support Level $5.58 $14.08
Resistance Level $6.20 $17.33
Average True Range (ATR) 0.26 1.50
MACD -0.02 0.10
Stochastic Oscillator 16.54 74.59

Price Performance

Historical Comparison
TZOO
STRO

About TZOO Travelzoo

Travelzoo acts as a publisher of travel and entertainment offers. It operates in four segments. Travelzoo North America segment, which is the key revenue driver, consists of operations in Canada and the U.S.; Travelzoo Europe segment consists of operations in France, Germany, Spain, and the U.K.; Jack's Flight Club segment consists of subscription revenue from premium members to access and receive flight deals from Jack's Flight Club via email or via Android or Apple mobile applications; and New Initiatives consists of Travelzoo's licensing activities in Asia Pacific territories. It derives its revenue through advertising fees including listing fees paid by travel, entertainment, and local businesses to advertise their offers on the company's media properties.

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

Share on Social Networks: